author-photo

Joshua F. Zeidner

University of North Carolina at Chapel Hill

81

Papers

695

Citations

Citation Trend

Filter By

Papers (61) Sort By

Journal Conference Others

Emerging therapies for AML with myelodysplasia-related changes: slowly but surely moving the needle.

2021 Expert Opinion on Emerging Drugs
- Davis F Phillips
- Joshua F. Zeidner
Show All
- Source
- Cite
- Save
Citations (0)
Clonal Compositions Involving Epigenetic Regulator Gene Mutations in Clonal Hematopoiesis, Clonal Cytopenias of Undetermined Significance and Chronic Myelomonocytic Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Characteristics and Clinical Outcome of Patients with Clonal Cytopenias of Undetermined Significance: A Large Retrospective Multi-Center International Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Real-World Management of Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax-Based Regimens: Results from the AML Real World Evidence (ARC) Initiative

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (16)
Genomic Characteristics and Prognostic Significance of Co-mutated ASXL1/SRSF2 Acute Myeloid Leukemia.

2021 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (2)
MDS-344: Pevonedistat Plus Azacitidine vs Azacitidine Alone in Higher-Risk Myelodysplastic Syndromes (MDS): Efficacy and Safety Results from Study P-2001 (NCT02610777)

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutations.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Prevalence of discordant QTc values among cancer patients by the Bazett, Fridericia, and Framingham formulae: Evidence for a standardized approach.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)